An updated Consensus Guideline by worldwide experts is now available:
See the publication of CLSI document NBS04-Ed2, Newborn Screening by Tandem Mass Spectrometry. The document is now available by the Clinical & Laboratory Standards Institute (CLSI), an institute that provides standards and guidelines for medical professionals through its unique consensus process.
Newborn Screening is an important part of preventive medicine that can be provided immediately after birth to identify babies at risk with potential life-threatening diseases. This published guideline is an important step to share knowledge and information by leading experts to all Newborn Screening laboratories worldwide.
ARCHIMEDlife’s team is dedicated to Newborn Screening and we are continuously working on novel laboratory tests and to offer a unique service to identify babies with life-threatening disorders at an early stage of life.
Stay in touch with us and visit our Healthcare Professional/ Babies‘ Health section to learn more about our laboratory tests that we offer.